- Home
- AQST vs RFI Comparison
AQST vs RFI Comparison
Compare AQST & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- RFI
- Stock Information
- Founded
- AQST 2004
- RFI 1992
- Country
- AQST United States
- RFI United States
- Employees
- AQST N/A
- RFI N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- RFI Investment Managers
- Sector
- AQST Health Care
- RFI Finance
- Exchange
- AQST Nasdaq
- RFI Nasdaq
- Market Cap
- AQST 285.4M
- RFI 311.2M
- IPO Year
- AQST 2018
- RFI N/A
- Fundamental
- Price
- AQST $3.01
- RFI $12.12
- Analyst Decision
- AQST Strong Buy
- RFI
- Analyst Count
- AQST 8
- RFI 0
- Target Price
- AQST $10.38
- RFI N/A
- AVG Volume (30 Days)
- AQST 2.0M
- RFI 69.8K
- Earning Date
- AQST 03-05-2025
- RFI 01-01-0001
- Dividend Yield
- AQST N/A
- RFI 8.25%
- EPS Growth
- AQST N/A
- RFI N/A
- EPS
- AQST N/A
- RFI N/A
- Revenue
- AQST $58,900,000.00
- RFI N/A
- Revenue This Year
- AQST $18.44
- RFI N/A
- Revenue Next Year
- AQST N/A
- RFI N/A
- P/E Ratio
- AQST N/A
- RFI N/A
- Revenue Growth
- AQST 22.56
- RFI N/A
- 52 Week Low
- AQST $2.24
- RFI $9.62
- 52 Week High
- AQST $6.23
- RFI $12.52
- Technical
- Relative Strength Index (RSI)
- AQST 43.29
- RFI 55.28
- Support Level
- AQST $2.95
- RFI $12.05
- Resistance Level
- AQST $3.21
- RFI $12.21
- Average True Range (ATR)
- AQST 0.20
- RFI 0.16
- MACD
- AQST 0.02
- RFI 0.01
- Stochastic Oscillator
- AQST 18.42
- RFI 76.03
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.